MEDICUBE VITA C PRO AMPOULE 20ML
Selling fast! 57 people have this in their carts.
Estimate delivery times: 1-2 days
Return within 24 hours of delivery.
Guaranteed Safe Checkout
MEDICUBE VITA C PRO AMPOULE 20ML
Description
The MEDICUBE AGE-R Vita C Pro Ampoule is a concentrated brightening ampoule with a 25% premium vitamin formula: 21% pure Vitamin C, 2% Vitamin B5 and 2% Vitamin C derivative. It targets melanin to fade the look of freckles, blemishes and dark spots, while helping skin look firmer and more radiant. The light golden texture comes in a dropper bottle for precise use.
Benefits
- High-purity 25% vitamin formula for melanin care
- Helps fade the look of freckles, blemishes and dark spots
- Evens out skin tone for a brighter, clearer complexion
- Helps improve skin texture, glow and firmness
- Absorbs better when used with the AGE-R Booster Pro device*
Key Ingredients
- Pure Vitamin C 21%: Brightens dull skin and targets the look of dark spots and uneven tone.
- Vitamin B5 2%: Moisturizes and soothes skin, balancing the strong vitamin C.
- Vitamin C Derivative 2%: A stable form of vitamin C that keeps brightening going for longer.
Clinical Results
After 4 weeks of use, the brand's human application test found improvements in blemishes (24.7%), dark spots (10.2%), pigmentation (1.01%), skin texture (6.8%), skin glow (1.5%) and pore elasticity (36.2%).**
How to Use
- After cleansing and toning, put 2–3 drops on your fingertips.
- Spread evenly over the face, focusing on dark spots and uneven areas.
- Pat gently until absorbed, then follow with moisturizer.
- For better absorption, use with the AGE-R Booster Pro device.
- If using in the morning, finish with sunscreen.
Tip: Strong vitamin C can tingle slightly. Patch test first and start with a few times a week if your skin is sensitive.
Product Details
- Brand: MEDICUBE AGE-R (Korea)
- Size: 20ml / 0.67 fl. oz.
- Packaging: Glass dropper bottle
- Skin Type: All skin types
*Brand claim: 785% better skin absorption when used with the AGE-R Booster Pro. **From the brand's human application test report (study period 20 March – 17 April 2023). Results may vary.





